Sort   by:  
 Page size 
UnknownMutations in GPAA1, Encoding a GPI Transamidase Complex Protein, Cause Developmental Delay, Epilepsy, Cerebellar Atrophy, and Osteopenia.
Not available
S-EPMC5673666 | biostudies-literature
UnknownComplex Compound Inheritance of Lethal Lung Developmental Disorders Due to Disruption of the TBX-FGF Pathway.
Not available
S-EPMC6369446 | biostudies-literature
UnknownADGRL1 haploinsufficiency causes a variable spectrum of neurodevelopmental disorders in humans and alters synaptic activity and behavior in a mouse model.
Not available
S-EPMC9388395 | biostudies-literature
UnknownDolutegravir as First- or Second-Line Treatment for HIV-1 Infection in Children.
Not available
S-EPMC7614690 | biostudies-literature
UnknownBREATHER Plus clinical trial design: A randomised non-inferiority trial evaluating the efficacy, safety and acceptability of short cycle (five days on, two days off) dolutegravir/tenofovir-based triple antiretroviral therapy (ART) compared to daily ART in virologically suppressed adolescents living with HIV aged 12 to <20 years in sub-Saharan Africa.
Not available
S-EPMC7617909 | biostudies-literature
UnknownOnce-daily dolutegravir/lamivudine fixed-dose formulations in children living with HIV: a pharmacokinetic and safety sub-study nested in the open-label, multicentre, randomised, non-inferiority D3/PENTA 21 trial.
Not available
S-EPMC12509724 | biostudies-literature
UnknownHMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials.
Not available
S-EPMC4322187 | biostudies-literature
Sort   by:  
 Page size